Innovative Research Award
Jeong Hyun Kim
Kangwon National University Hospital, South Korea
| Jeong Hyun Kim |
| Affiliation |
Kangwon National University Hospital |
| Country |
South Korea |
| Scopus ID |
57207436992 |
| Documents |
34 |
| Citations |
622 |
| h-index |
17 |
| Subject Area |
Innovation Management |
| Event |
Business Global Awards |
Jeong Hyun Kim is a researcher affiliated with Kangwon National University Hospital whose scholarly record includes work addressing prostate cancer, clinical consensus development, patient-related digital engagement, and regional epidemiological patterns. The available publication record includes peer-reviewed studies published in 2023 and 2025, providing a basis for considering the researcher’s contribution to evidence-oriented innovation in healthcare. [1]
Abstract
This academic recognition profile presents Jeong Hyun Kim in relation to the Innovative Research Award and the field of Innovation Management. The documented research portfolio includes studies on metastatic hormone-sensitive prostate cancer, digital patient-association engagement through the metaverse, and longitudinal prostate cancer risk patterns in a Korean province. These studies illustrate the application of structured evidence generation, multidisciplinary collaboration, digital approaches, and regional health data to contemporary healthcare research. [1] [2]
Keywords
- Innovation Management
- Prostate Cancer Research
- Clinical Consensus
- Digital Health
Introduction
Innovation in contemporary healthcare increasingly depends on combining clinical evidence with digital tools, collaborative methodologies, and population-level data. Research addressing these dimensions can support more consistent clinical decision-making and improve understanding of changing healthcare environments. Kim’s documented publications reflect this interdisciplinary orientation, particularly within prostate cancer research and digital health communication. [2]
Research Profile
The reported Scopus record lists 34 documents, 622 citations, and an h-index of 17 under Scopus Author ID 57207436992. These indicators provide bibliometric context for the researcher’s scholarly visibility, although publication counts and citation measures should be interpreted alongside research quality, methodological contribution, and field-specific context. [1]
Research Contributions
The 2025 modified Delphi study on metastatic hormone-sensitive prostate cancer contributes to consensus-oriented clinical research in South Korea. A separate 2025 cross-sectional survey examined the use of the metaverse by prostate cancer patient associations during the Blue Ribbon Campaign, representing an application of digital environments to patient engagement. Earlier multicenter research investigated stratified prostate cancer risk trends from 2003 to 2021 using regional training-hospital data. [2] [3]
Publications
- Establishing consensus recommendations for metastatic hormone-sensitive prostate cancer in South Korea: A modified Delphi study. Investigative and Clinical Urology, 2025. [2]
- Analyzing Usage of the Metaverse by Associations of Patients With Prostate Cancer During the 2023 Blue Ribbon Campaign: Cross-Sectional Survey Study. Journal of Medical Internet Research, 2025. [3]
- Trends of stratified prostate cancer risk in a single Korean province from 2003 to 2021: A multicenter study conducted using regional training hospital data. Investigative and Clinical Urology, 2023. [4]
Research Impact
The reported citation record indicates that Kim’s publications have received scholarly attention, while the individual studies demonstrate relevance to clinical recommendations, patient-facing digital communication, and regional epidemiology. The combination of these themes is consistent with an innovation-oriented research profile in which established clinical methods are examined alongside emerging digital and data-driven approaches. [1]
Award Suitability
Kim’s documented research is potentially aligned with an Innovative Research Award through its combination of clinical evidence synthesis, digital health exploration, and epidemiological analysis. The portfolio demonstrates multiple approaches to addressing healthcare questions rather than relying on a single methodological perspective. Final award assessment should consider the originality, reproducibility, practical relevance, and independent contribution of the researcher’s work in accordance with the award’s formal evaluation criteria.
Conclusion
Jeong Hyun Kim’s research profile combines prostate cancer clinical research with digital health and population-level investigation. The available bibliometric indicators and selected publications provide a documented basis for scholarly recognition, while the methodological diversity of the work supports consideration within an innovation-focused academic award framework.
External Links
References
- Elsevier. (n.d.). Scopus author details: Jeong Hyun Kim, Author ID 57207436992. Scopus.
https://www.scopus.com/pages/authors/57207436992
- Joung, J., Jeong, I.-g., Kang, S.-g., et al. (2025). Establishing consensus recommendations for metastatic hormone-sensitive prostate cancer in South Korea: A modified Delphi study. Investigative and Clinical Urology.
- Jo, J., Kim, Y., Ha, Y.-s., et al. (2025). Analyzing Usage of the Metaverse by Associations of Patients With Prostate Cancer During the 2023 Blue Ribbon Campaign: Cross-Sectional Survey Study. Journal of Medical Internet Research.
- Ko, Y., Kim, B.-h., Kwon, S.-y., et al. (2023). Trends of stratified prostate cancer risk in a single Korean province from 2003 to 2021: A multicenter study conducted using regional training hospital data. Investigative and Clinical Urology.
- World Health Organization. (2021). Global strategy on digital health 2020–2025. World Health Organization.
- National Cancer Institute. (n.d.). Prostate cancer research and clinical information. National Cancer Institute.